Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Cash from Operations (2018 - 2025)

Avai Bio's Cash from Operations history spans 6 years, with the latest figure at 136522.0 for Q1 2024.

  • On a quarterly basis, Cash from Operations fell 85.76% to 136522.0 in Q1 2024 year-over-year; TTM through Mar 2024 was 1322318.0, a 2328.19% decrease, with the full-year FY2025 number at 1160610.0, up 12.23% from a year prior.
  • Cash from Operations hit 136522.0 in Q1 2024 for Avai Bio, up from 705669.0 in the prior quarter.
  • Over the last five years, Cash from Operations for AVAI hit a ceiling of 109582.0 in Q1 2020 and a floor of 705669.0 in Q4 2023.
  • Historically, Cash from Operations has averaged 129119.4 across 4 years, with a median of 66609.5 in 2023.
  • Biggest five-year swings in Cash from Operations: soared 4929.53% in 2020 and later tumbled 2265.56% in 2023.
  • Tracing AVAI's Cash from Operations over 4 years: stood at 24001.0 in 2020, then skyrocketed by 235.77% to 32586.0 in 2022, then tumbled by 2265.56% to 705669.0 in 2023, then skyrocketed by 80.65% to 136522.0 in 2024.
  • Business Quant data shows Cash from Operations for AVAI at 136522.0 in Q1 2024, 705669.0 in Q4 2023, and 420401.0 in Q3 2023.